COLESTROLESS 500MG 30 F.C. TABS

COLESTILAN (COLESTIMIDE) IS A MEDICATION THAT ACTS AS A PHOSPHATE BINDER AND BILE ACID SEQUESTRANT. IT IS AN ION-EXCHANGE RESIN IS AN ORALLY ADMINISTERED BILE ACID SEQUESTRANT THAT IS BEING DEVELOPED BY MITSUBISHI TANABE PHARMA CORPORATION FOR THE TREATMENT OF HYPERCHOLESTEROLAEMIA AND HYPERPHOSPHATAEMIA. IT HAS BEEN LAUNCHED IN JAPAN FOR HYPERCHOLESTEROLAEMIA. FOR THE TREATMENT OF HYPERPHOSPHATAEMIA IT IS LAUNCHED IN AUSTRIA GERMANY THE CZECH REPUBLIC PORTUGAL AND THE UNITED KINGDOM IS REGISTERED IN THE EU. PHASE III DEVELOPMENT IN PAEDIATRIC PATIENTS WITH HYPERPHOSPHATAEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE WAS UNDERWAY IN THE UK AND GERMANY. HOWEVER THE COMPANY DISCONTINUED THE DEVELOPMENT. IN ADDITION THE PHASE II DEVELOPMENT IN TYPE-2 DIABETES MELLITUS AND PHASE I DEVELOPMENT IN HYPERPHOSPHATAEMIA IN JAPAN WAS ALSO DISCONTINUED BY THE COMPANY.